193 related articles for article (PubMed ID: 9104548)
1. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.
Elewski BE; Scher RK; Aly R; Daniel R; Jones HE; Odom RB; Zaias N; Jacko ML
Cutis; 1997 Apr; 59(4):217-20. PubMed ID: 9104548
[TBL] [Abstract][Full Text] [Related]
2. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
3. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail.
Odom R; Daniel CR; Aly R
J Am Acad Dermatol; 1996 Jul; 35(1):110-1. PubMed ID: 8682945
[No Abstract] [Full Text] [Related]
5. Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.
Maddin S; Quiring J; Bulger L
J Drugs Dermatol; 2013 Jul; 12(7):758-63. PubMed ID: 23884486
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T
Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738
[TBL] [Abstract][Full Text] [Related]
7. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.
Jones HE; Zaias N
Int J Dermatol; 1996 Aug; 35(8):589-90. PubMed ID: 8854164
[No Abstract] [Full Text] [Related]
9. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
Warrick D; Church L
J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
[No Abstract] [Full Text] [Related]
10. Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis.
De Doncker P; Van Lint J; Dockx P; Roseeuw D
Cutis; 1995 Sep; 56(3):180-3. PubMed ID: 8565605
[TBL] [Abstract][Full Text] [Related]
11. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Del Rosso JQ
J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
[TBL] [Abstract][Full Text] [Related]
12. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
Sigurgeirsson B; van Rossem K; Malahias S; Raterink K
J Am Acad Dermatol; 2013 Sep; 69(3):416-25. PubMed ID: 23706639
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
Aman S; Akbar TM; Hussain I; Jahangir M; Haroon TS
J Coll Physicians Surg Pak; 2003 Nov; 13(11):618-20. PubMed ID: 14700485
[TBL] [Abstract][Full Text] [Related]
14. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
Lecha M
Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
[TBL] [Abstract][Full Text] [Related]
15. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
16. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Kejda J
Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of extensive onychomycosis in aged patients].
Maleszka R; Adamski Z
Wiad Parazytol; 2001; 47(4):817-22. PubMed ID: 16886433
[TBL] [Abstract][Full Text] [Related]
19. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
[TBL] [Abstract][Full Text] [Related]
20. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
Syed TA; Ahmadpour OA; Ahmad SA; Shamsi S
J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
